Mirum Pharmaceuticals, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 1.34x
Net debt / equity: -0.00x
Debt / assets: 0.36x
Debt / EBITDA: -0.43x
Net debt / EBITDA: 0.00x

Liquidity & coverage

Current ratio: 2.09x
Quick ratio: 1.99x
Cash ratio: 1.42x
Interest coverage: -4.87x
EBITDA / interest: -52.83x
Working capital: $296.6M

Cash & dividend

FCF / debt: -0.53x
Cash flow / debt: -0.53x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.